Anti-USP48 monoclonal antibody

Pre-made anti-USP48 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to USP48/USP48 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2256-Ab-1/ GM-Tg-hg-IP2256-Ab-2Anti-Human USP48 monoclonal antibodyHuman
GM-Tg-rg-IP2256-Ab-1/ GM-Tg-rg-IP2256-Ab-2Anti-Rat USP48 monoclonal antibodyRat
GM-Tg-mg-IP2256-Ab-1/ GM-Tg-mg-IP2256-Ab-2Anti-Mouse USP48 monoclonal antibodyMouse
GM-Tg-cynog-IP2256-Ab-1/ GM-Tg-cynog-IP2256-Ab-2Anti-Cynomolgus/ Rhesus macaque USP48 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2256-Ab-1/ GM-Tg-felg-IP2256-Ab-2Anti-Feline USP48 monoclonal antibodyFeline
GM-Tg-cang-IP2256-Ab-1/ GM-Tg-cang-IP2256-Ab-2Anti-Canine USP48 monoclonal antibodyCanine
GM-Tg-bovg-IP2256-Ab-1/ GM-Tg-bovg-IP2256-Ab-2Anti-Bovine USP48 monoclonal antibodyBovine
GM-Tg-equg-IP2256-Ab-1/ GM-Tg-equg-IP2256-Ab-2Anti-Equine USP48 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2256-Ab-1/ GM-Tg-hg-IP2256-Ab-2; GM-Tg-rg-IP2256-Ab-1/ GM-Tg-rg-IP2256-Ab-2;
GM-Tg-mg-IP2256-Ab-1/ GM-Tg-mg-IP2256-Ab-2; GM-Tg-cynog-IP2256-Ab-1/ GM-Tg-cynog-IP2256-Ab-2;
GM-Tg-felg-IP2256-Ab-1/ GM-Tg-felg-IP2256-Ab-2; GM-Tg-cang-IP2256-Ab-1/ GM-Tg-cang-IP2256-Ab-2;
GM-Tg-bovg-IP2256-Ab-1/ GM-Tg-bovg-IP2256-Ab-2; GM-Tg-equg-IP2256-Ab-1/ GM-Tg-equg-IP2256-Ab-2
Products NameAnti-USP48 monoclonal antibody
Formatmab
Target NameUSP48
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-USP48 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2256-Ag-1Recombinant multi-species UBP48/ USP48/ RAP1GA1 protein


    Target information

    Target IDGM-IP2256
    Target NameUSP48
    Gene ID84196,170707,362636,707110,478198,101094032,100141158,100058232
    Gene Symbol and Synonyms2810449C13Rik,D330022K21Rik,DFNA85,RAP1GA1,synUSP,USP31,USP48
    Uniprot AccessionQ86UV5,Q76LT8
    Uniprot Entry NameUBP48_HUMAN,UBP48_RAT
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000090686
    Target ClassificationN/A

    The target: USP48, gene name: USP48, also named as RAP1GA1, USP31. This gene encodes a protein containing domains that associate it with the peptidase family C19, also known as family 2 of ubiquitin carboxyl-terminal hydrolases. Family members function as deubiquitinating enzymes, recognizing and hydrolyzing the peptide bond at the C-terminal glycine of ubiquitin. Enzymes in peptidase family C19 are involved in the processing of poly-ubiquitin precursors as well as that of ubiquitinated proteins. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.